General Information
Revision date
2019-01-04
Product name
Terbutaline Sulfate Tablets, USP, 2.5mg, 5mg
CAS No.
23031-32-5
1.2.1 Relevant identified uses
Oral
Manufacturer Name
TWi Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
TWi Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
QA.Service@twipharma.com
Section 2
Hazard statements
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation
Additional information
Not available. Carcinogenic Effect Not available. Mutagenic Effect Not available.
Teratogenic Effects
Repeated or prolonged exposure is not known to aggravate medical condition. Developmental Toxicity
